PADI4 and rheumatoid arthritis: Furthermore, serum ACPA positivity is high in the pre-clinical phase of RA while our current study and published data demonstrate that serum anti-PAD4 antibodies are much less frequent in the pre-clinical phase and are associated with longer RA disease duration [4, 9, 21].